In AR-positive LNCaP prostate cancer cells, 5α-dihydrotestosterone (DHT) significantly increased the expression levels of ASCT2 and glutaminase (GLS), the enzyme responsible for the deamination of glutaminase to glutamate. The gene discussed is GLS; the disease is prostate cancer.